Clinical Trial Update: Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing vonoprazan to esomeprazole in symptomatic GERD patients who partly responded to high-dose PPIs; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Vonoprazan (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux | Phase 2 | Status: COMPLETED | Results posted: 2020-02-18